Combinatorial Chemistry & High Throughput Screening
Title:Editorial: Advanced Big-Data Analysis Methods and Tools for High-Throughput Omics Technologies
Volume: 20 Issue: 2
Author(s): Tao Huang*
Affiliation:
- Director of Bioinformatics Core Facility Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031,China
Export Options
About this article
Cite this article as:
Huang Tao*, Editorial: Advanced Big-Data Analysis Methods and Tools for High-Throughput Omics Technologies, Combinatorial Chemistry & High Throughput Screening 2017; 20(2) . https://dx.doi.org/10.2174/138620732002170601151524
| DOI https://dx.doi.org/10.2174/138620732002170601151524 |
Print ISSN 1386-2073 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Article Metrics
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
CYP Epoxygenase Derived EETs: From Cardiovascular Protection to Human Cancer Therapy
Current Topics in Medicinal Chemistry Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Current Cancer Drug Targets Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells
Current Molecular Medicine Cyclooxygenases in Cancer: Chemoprevention and Sensitization to Conventional Therapies
Mini-Reviews in Medicinal Chemistry Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer
Drug Metabolism Letters Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Molecular Probes for Malignant Melanoma Imaging
Current Pharmaceutical Biotechnology Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry The Genetic Basis of New Treatment Modalities in Melanoma
Current Drug Targets Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Role of Copper in Angiogenesis and Its Medicinal Implications
Current Medicinal Chemistry Lung Cancer May Increase Serum Procalcitonin Level
Infectious Disorders - Drug Targets Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells
MicroRNA Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Integrative Analysis of miRNA-mediated Competing Endogenous RNA Network Reveals the lncRNAs-mRNAs Interaction in Glioblastoma Stem Cell Differentiation
Current Bioinformatics Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry
© 2022 Bentham Science Publishers | Privacy Policy




